November 14, 2023 @ 8:00 AM – November 15, 2023 @ 5:00 PM
Hear from and meet with the leading figures in biomarker analysis to explore how companies are innovating in biomarker analysis to accelerate timelines and reduce risk in drug development, with in-depth consideration of the latest multiplexed and cytometry tools impacting biomarker research & validation.
Mario Richter – AbbVie Deutschland GmbH & Co. KG
Eike Staub – Merck
Siôn Lewis – UCB BioPharma
Li Chin Wong – Prevail Therapeutics
Priyank Patel – Boehringer Ingelheim
Polina Goihberg – Pfizer